The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-UK detects South African coronavirus variant in people with no travel links

Mon, 01st Feb 2021 12:28

* Eleven cases in England with no direct connection with S.
Africa

* Public Health England says 105 cases of new variant
detected

* Mass testing to start in eight areas to contain spread
(Adds comments from health secretary, Public Health England)

By Paul Sandle

LONDON, Feb 1 (Reuters) - Eleven people in different regions
of England have tested positive for the South African
coronavirus variant without having any links to people who have
travelled, prompting mass testing in the areas to contain the
outbreak.

Britain, with the world's fifth-highest COVID-19 death toll,
has moved to tighten its borders out of concern that new
variants of the virus will undermine its vaccination drive.

To contain the new outbreaks, residents in eight areas of
the country will now be tested whether or not they are showing
symptoms, a process known as "surge testing".

There are about 10,000 people in each area. Three are in
London, two in the southeast, one in central England, one in the
east and another in the northwest.

Health minister Matt Hancock said those in the affected
areas needed to comply with the request to be tested, even if
they are asymptomatic, to break any chain of transmission.

"There's currently no evidence to suggest this variant is
any more severe," he said. "But we need to come down on it hard,
and we will."

Positive tests in the areas will be sequenced to identify
any further spread of the variant.

All viruses mutate, and scientists have identified several
variants of the coronavirus found to be more transmissible than
the original strain.

Their emergence has raised questions over whether vaccines
will still prove effective.

Public Health England said it has identified a total of 105
cases of the South African variant since Dec 22.

Scientists have said it appears to be more transmissible,
but there is no evidence that it causes more severe disease.
However, several laboratory studies have found that it reduces
vaccine and antibody therapy efficacy.

Simon Clarke, associate professor in cellular microbiology
at the University of Reading, said there was emerging evidence
to suggest the variant was less susceptible to immunity induced
by the current crop of vaccines.

"The discovery of a handful of cases with no links to travel
to Africa indicates that it might be more widespread in the
community than previously thought," he said.

"This spread, even if small in scale, needs to be brought
under control quickly, so Public Health England's house-to-house
checks and intensive testing are the right thing to do."

Public Health England's Managing Director Susan Hopkins said
the cases did not appear linked.

"They're more likely to be related to somebody who
potentially had asymptomatic infection when they came in from
abroad," she said at a news conference.

Britain is battling a new wave of COVID-19 turbocharged by
the emergence in September of a more transmissable variant found
in the southeast of England. The country's official death toll
passed 100,000 last week.
Britain is, however, making rapid progress in its vaccination
programme, with nearly 9.3 million people having received the
first shot of either the Pfizer-BioNTech or
Oxford-AstraZeneca shot.
(Reporting by Kate Holton, Michael Holden and Paul Sandle
Editing by Estelle Shirbon, Timothy Heritage and David Goodman
)

More News
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.